血液系统恶性肿瘤的总血清N-糖组图谱
该研究通过多中心大队列(回顾性n=1,370,前瞻性纵向n=130)分析主要血液系统恶性肿瘤的总血清N-糖组(TSNG),定义了多发性骨髓瘤、淋巴瘤和急性白血病诊断时不同的TSNG谱,发现关键聚糖在完全缓解时显著下降、复发时再次升高,ROC分析支持TSNG区分疾病状态并评估治疗反应。
要点
- TSNG可区分多发性骨髓瘤、淋巴瘤和急性白血病的诊断及亚型。
- 关键聚糖水平随疾病状态变化:完全缓解时下降,复发时升高。
- TSNG有潜力用于评估治疗反应和监测疾病状态。
核心结论
- 系统绘制了血液系统恶性肿瘤的TSNG图谱,支持其在诊断、亚型分型和治疗监测中的临床相关性。
研究设计与样本
- 多中心大队列分析,结合回顾性(n=1,370)和前瞻性纵向(n=130)数据,覆盖主要血液系统恶性肿瘤类型。
主要发现
- 在多发性骨髓瘤、淋巴瘤和急性白血病诊断时定义了不同的TSNG谱,揭示共享和疾病特异性特征。
- TSNG特征随疾病状态改变,关键聚糖在完全缓解时显著下降,复发时再次升高。
- ROC曲线分析表明TSNG可区分疾病状态,支持其评估治疗反应的效用。
临床怎么用
- TSNG谱有望作为辅助工具用于血液系统恶性肿瘤的诊断、亚型分型和治疗反应监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A holistic and dynamic view of the glycomic landscape in hematological malignancies (HMs) remains poorly characterized, hindering clinical the application of glycomics in HMs. We launched a large-scale analysis of multicenter cohorts, combining retrospective (n=1,370) and prospective longitudinal (n=130) data across major HM types. We defined distinct total serum N‑glycome (TSNG) profiles for multiple myeloma, lymphoma, and acute leukemia at diagnosis, revealing shared and disease-specific signatures that support their diagnostic and subtyping potential. TSNG features changed with disease status. Key glycans decreased significantly upon complete remission and increased again at relapse. Receiver operating characteristic curve analyses demonstrated that TSNG could distinguish disease states, supporting its utility for assessing treatment response. We systematically mapped the TSNG landscape of HMs, established its clinical relevance across diagnosis, subtyping, and treatment monitoring, providing a framework for advancing the glycomics-based understanding and management of these malignancies.
引用
- Xu Y, Dong X, Zhang J, et al. The total serum N-glycome landscape of hematological malignancies. Blood Adv. 2026. PMID: 42837669. doi:10.1182/bloodadvances.2026020546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。